Skip to content

Clinical efficacy study of percutaneous spinal cord electrical stimulation on walking function in stroke patients

Efficacy of Spatiotemporally Specific Spinal Cord Stimulation on Gait Function in Patients With Stroke: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128035
Enrollment
Unknown
Registered
2026-07-13
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Sham stimulation group:Rehabiliation combined with sham stimulation
Transcutaneous spinal cord stimulation group:Rehabilitation combined with transcutaneous spinal cord stimulation

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with stroke by cranial CT or MRI, including cerebral infarction, cerebral hemorrhage, and cerebral embolism; 2. Aged 18–75 years, with first-ever stroke and a disease duration of 1–6 months; 3. Obvious unilateral lower-limb motor impairment, with the ability to complete gait-related assessments and training independently or with assistance; 4. No significant lower-limb spasticity, defined as a lower-limb Modified Ashworth Scale score <1; 5. No severe cognitive or language impairment; 6. Willingness to participate in the trial and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Comorbid other neurological diseases; 2. Obvious language impairment, cognitive impairment, hemispatial neglect, or psychiatric disorders that prevent cooperation with training and assessments; 3. History of epilepsy; 4. Comorbid fractures or other conditions affecting lower-limb motor function; 5. Significant sensory impairment in the lower back or lower limbs; 6. Obvious skull defect or other factors that may interfere with EEG signal acquisition during training; 7. Inability to cooperate with treatment or examinations for other reasons; 8. Participation in other clinical trials or receipt of spinal cord stimulation therapy within the past three months.

Design outcomes

Primary

MeasureTime frame
walking time at 10 Minutes Walking Test;

Secondary

MeasureTime frame
Movement-related event-related desynchronization/synchronization (ERD/ERS);Intermuscular coherence;Fugl-Meyer for lower limb;beta-band corticomuscular coherence;Functional Ambulation Catergory;Berg Balance Scale;

Countries

China

Contacts

Public ContactPan Yu

Beijing Tsinghua Changgung Hospital

py10335@163.com+86 10 56118926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026